<DOC>
	<DOC>NCT00543686</DOC>
	<brief_summary>Explorative comparison of montelukast with inhaled steroids (fluticasone) to estimate responder profiles, in terms of symptom scores, rescue medication, increase of FEV1, in correlation to presence of allergy, bronchial hyperreactivity (PD20), exhaled NO, excretion of leukotrienes, response to RABA and laboratory parameters in patients with pre-school asthma i.e. asthma phenotypes.</brief_summary>
	<brief_title>Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Male or female patients age 4 6 years Diagnosis of mild intermittent bronchial asthma (Step III) in the past 6 12 months as stated by the investigator: Use of inhaled beta2agonists &lt; 1/week (max 3 puff /d) Exacerbationfree interval &gt; 4 weeks prior to visit 1 The written informed consent of parents after received written and oral information about the aim, purpose and risks of the study must be present Asthma severity â‰¥ Step 2 Severe concomitant diseases Suspected noncompliance age below 4 and age above 7 years last study participation &lt; 30 days</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Pre-School Asthma</keyword>
	<keyword>Responder Profiles</keyword>
	<keyword>Fluticasone</keyword>
	<keyword>Montelukast</keyword>
	<keyword>Leukotriene</keyword>
	<keyword>Children with Pre-School Asthma</keyword>
</DOC>